HCA
AGIO icon

Harbor Capital Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Harbor Capital Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Buy
46,550
+3,545
+8% +$108K 0.12% 250
2026
Q1 		$1.46M Buy
43,005
+5,777
+16% +$164K 0.12% 251
2025
Q4 		$1.01M Buy
37,228
+2,393
+7% +$84K 0.08% 320
2025
Q3 		$1.4M Sell
34,835
-2,189
-6% -$82.3K 0.11% 258
2025
Q2 		$1.23M Buy
37,024
+1,295
+4% +$39.3K 0.05% 404
2025
Q1 		$1.05M Buy
35,729
+1,962
+6% +$65.1K 0.05% 426
2024
Q4 		$1.11M Sell
33,767
-5,323
-14% -$250K 0.05% 427
2024
Q3 		$1.74M Buy
39,090
+6,320
+19% +$287K 0.08% 339
2024
Q2 		$1.41M Buy
32,770
+13,494
+70% +$487K 0.11% 273
2024
Q1 		$564K Buy
+19,276
New +$516K 0.07% 358

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Harbor Capital Advisors's AGIO Position: Q2 2026 in Review

Harbor Capital Advisors increased its Agios Pharmaceuticals (AGIO) stake by 8.2% in Q2 2026, buying an estimated $108K and bringing the position to 46,550 shares worth $1.73M. The position accounts for 0.12% of the portfolio, ranked #250.

Harbor Capital Advisors first reported a position in AGIO in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.74M in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Harbor Capital Advisors held 46,550 shares of Agios Pharmaceuticals worth $1.73M as of Q2 2026.
  • Harbor Capital Advisors bought 3,545 Agios Pharmaceuticals shares in Q2 2026, an estimated $108K.
  • Agios Pharmaceuticals made up 0.12% of Harbor Capital Advisors's portfolio in Q2 2026, its #250 holding.
  • Harbor Capital Advisors first reported a position in Agios Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Harbor Capital Advisors's Agios Pharmaceuticals position peaked at $1.74M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.